180 related articles for article (PubMed ID: 9070608)
21. Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P450IA in lung cancer patients.
Anttila S; Hietanen E; Vainio H; Camus AM; Gelboin HV; Park SS; Heikkilä L; Karjalainen A; Bartsch H
Int J Cancer; 1991 Mar; 47(5):681-5. PubMed ID: 1848536
[TBL] [Abstract][Full Text] [Related]
22. Cytochrome P450 3A5 is highly expressed in normal prostate cells but absent in prostate cancer.
Leskelä S; Honrado E; Montero-Conde C; Landa I; Cascón A; Letón R; Talavera P; Cózar JM; Concha A; Robledo M; Rodríguez-Antona C
Endocr Relat Cancer; 2007 Sep; 14(3):645-54. PubMed ID: 17914095
[TBL] [Abstract][Full Text] [Related]
23. Differential drug-induced mRNA expression of human CYP3A4 compared to CYP3A5, CYP3A7 and CYP3A43.
Krusekopf S; Roots I; Kleeberg U
Eur J Pharmacol; 2003 Apr; 466(1-2):7-12. PubMed ID: 12679136
[TBL] [Abstract][Full Text] [Related]
24. Regulation of CYP3A5 by glucocorticoids and cigarette smoke in human lung-derived cells.
Hukkanen J; Väisänen T; Lassila A; Piipari R; Anttila S; Pelkonen O; Raunio H; Hakkola J
J Pharmacol Exp Ther; 2003 Feb; 304(2):745-52. PubMed ID: 12538830
[TBL] [Abstract][Full Text] [Related]
25. Factors influencing midazolam hydroxylation activity in human liver microsomes.
He P; Court MH; Greenblatt DJ; von Moltke LL
Drug Metab Dispos; 2006 Jul; 34(7):1198-207. PubMed ID: 16638818
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome p450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: correlation with alprazolam pharmacokinetics.
Gashaw I; Kirchheiner J; Goldammer M; Bauer S; Seidemann J; Zoller K; Mrozikiewicz PM; Roots I; Brockmöller J
Clin Pharmacol Ther; 2003 Nov; 74(5):448-57. PubMed ID: 14586385
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of human cytochrome P450 enzymes from the CYP3A subfamily in the brains of alcoholic subjects and drug-free controls.
Booth Depaz IM; Toselli F; Wilce PA; Gillam EM
Drug Metab Dispos; 2013 Jun; 41(6):1187-94. PubMed ID: 23491640
[TBL] [Abstract][Full Text] [Related]
28. Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues.
McKinnon RA; Burgess WM; Hall PM; Roberts-Thomson SJ; Gonzalez FJ; McManus ME
Gut; 1995 Feb; 36(2):259-67. PubMed ID: 7883227
[TBL] [Abstract][Full Text] [Related]
29. The CYP3A4*1B allele increases risk for small cell lung cancer: effect of gender and smoking dose.
Dally H; Edler L; Jäger B; Schmezer P; Spiegelhalder B; Dienemann H; Drings P; Schulz V; Kayser K; Bartsch H; Risch A
Pharmacogenetics; 2003 Oct; 13(10):607-18. PubMed ID: 14515059
[TBL] [Abstract][Full Text] [Related]
30. Decreased expression of cytochrome P450 protein in non-malignant colonic tissue of patients with colonic adenoma.
Bergheim I; Bode C; Parlesak A
BMC Gastroenterol; 2005 Nov; 5():34. PubMed ID: 16281975
[TBL] [Abstract][Full Text] [Related]
31. Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism.
Lin YS; Dowling AL; Quigley SD; Farin FM; Zhang J; Lamba J; Schuetz EG; Thummel KE
Mol Pharmacol; 2002 Jul; 62(1):162-72. PubMed ID: 12065767
[TBL] [Abstract][Full Text] [Related]
32. Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues.
Macé K; Bowman ED; Vautravers P; Shields PG; Harris CC; Pfeifer AM
Eur J Cancer; 1998 May; 34(6):914-20. PubMed ID: 9797707
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of human intestinal wall metabolism by macrolide antibiotics: effect of clarithromycin on cytochrome P450 3A4/5 activity and expression.
Pinto AG; Wang YH; Chalasani N; Skaar T; Kolwankar D; Gorski JC; Liangpunsakul S; Hamman MA; Arefayene M; Hall SD
Clin Pharmacol Ther; 2005 Mar; 77(3):178-88. PubMed ID: 15735612
[TBL] [Abstract][Full Text] [Related]
34. Expression of cytochrome P450 3A4 in foveolar epithelium with intestinal metaplasia of the human stomach.
Yokose T; Doy M; Kakiki M; Horie T; Matsuzaki Y; Mukai K
Jpn J Cancer Res; 1998 Oct; 89(10):1028-32. PubMed ID: 9849581
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells.
Medina PP; Carretero J; Ballestar E; Angulo B; Lopez-Rios F; Esteller M; Sanchez-Cespedes M
Hum Mol Genet; 2005 Apr; 14(7):973-82. PubMed ID: 15731117
[TBL] [Abstract][Full Text] [Related]
36. Transcription factor binding to a putative double E-box motif represses CYP3A4 expression in human lung cells.
Biggs JS; Wan J; Cutler NS; Hakkola J; Uusimäki P; Raunio H; Yost GS
Mol Pharmacol; 2007 Sep; 72(3):514-25. PubMed ID: 17548528
[TBL] [Abstract][Full Text] [Related]
37. Cytochrome P450 CYP3A in human renal cell cancer.
Murray GI; McFadyen MC; Mitchell RT; Cheung YL; Kerr AC; Melvin WT
Br J Cancer; 1999 Apr; 79(11-12):1836-42. PubMed ID: 10206301
[TBL] [Abstract][Full Text] [Related]
38. Association of CYP3A4, CYP3A5 polymorphisms with lung cancer risk in Bangladeshi population.
Islam MS; Mostofa AG; Ahmed MU; Bin Sayeed MS; Hassan MR; Hasnat A
Tumour Biol; 2014 Feb; 35(2):1671-8. PubMed ID: 24085358
[TBL] [Abstract][Full Text] [Related]
39. [The relationship between cytochrome P450, subfamily IIIA, polypeptide 5 gene and drug resistance in leukemia cell lines].
Wang T; Chen FY; Han JY; Zhong JH; Teng Y; Ouyang RR
Zhonghua Nei Ke Za Zhi; 2004 Jul; 43(7):527-9. PubMed ID: 15312409
[TBL] [Abstract][Full Text] [Related]
40. Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes.
Dennison JB; Jones DR; Renbarger JL; Hall SD
J Pharmacol Exp Ther; 2007 May; 321(2):553-63. PubMed ID: 17272675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
